Navigation Links
High BPA levels in children associated with higher risk of obesity and abnormal waist circumference
Date:8/19/2013

Ann Arbor, Mich. Children who have higher levels of Bisphenol A (BPA), a chemical previously used in many products for kids, like baby bottle and plastic toys, had a higher odds of obesity and adverse levels of body fat, according to a new study from University of Michigan researchers.

The U-M team studied the levels of BPA found in children's urine and then measured body fat, waist circumference, and cardiovascular and diabetes risk factors, in a study published today in Pediatrics.

BPA was previously widely used in the manufacturing of polycarbonate and epoxy resins used in a variety of products for children, including baby bottles, protective coatings on metal food containers, plastic toys, and dental sealants.

"Studies in adults had shown an association between high BPA levels and obesity, diabetes and cardiovascular disease, but little was known about its effects in children," says Donna Eng, M.D., lead author of the study and recent graduate of the Pediatric Endocrinology Fellowship at C.S. Mott Children's Hospital.

The study found that higher odds of obesity, defined as a BMI above the 95th percentile on Centers for Disease Control and Prevention growth curves, was associated with higher levels of urinary BPA. Researchers also found that children with higher BPA levels also were more likely to have an abnormal waist circumference-to-height ratio.

The study did not find significant associations of BPA with any other chronic disease factors, including abnormal levels of cholesterol, insulin or glucose levels.

"Our study suggests a possible link between BPA exposure and childhood obesity. We therefore need more longitudinal studies to determine if there is a causal link between BPA and excess body fat." says Eng.

Manufacturers have been voluntarily recalling BPA products due to suspicion about the toxic effects on children and other vulnerable populations. Many countries, including Canada and members of the European Union, as well as several U.S. states, have banned BPA use in products frequently used by infants and young children.

In July 2012, the U.S. Food and Drug Administration announced that baby bottles and children's drinking cups could no longer contain BPA; however, this restriction does not apply to other BPA containing products.

"We were surprised that our study did not find an association between BPA and measures of cardiovascular and diabetes risk, which has been established among adults," says Joyce Lee, M.D., M.P.H, associate professor of Pediatrics at C.S. Mott Children's Hospital.

"Based on these results, BPA may not have adverse effects on cardiovascular and diabetes risk, but it's certainly possible that the adverse effects of BPA could compound over time, with health effects that only later manifest in adulthood," says Lee, an investigator in U-M's Child Health Evaluation and Research Unit and assistant professor of Environmental Health Sciences in the U-M School of Public Health.

Investigators hope the study will prompt more research into BPA's effects that can inform future policy regulating children's consumer products.


'/>"/>

Contact: Mary F. Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Normal triglyceride levels in people of African descent may hinder diagnosis of metabolic syndrome
2. Heart failure patients with diabetes may benefit from higher glucose levels
3. Cholesterol Levels Vary Widely by Country: Study
4. Low oxygen levels could drive cancer growth
5. Liver fat gets a wake-up call that maintains blood sugar levels
6. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
7. Dieting May Lower Hormone Levels Tied to Breast Cancer
8. Revised ARDS definition sets out levels of severity
9. Aggressively controlling glucose levels may not reduce kidney failure in Type 2 diabetes
10. New device warns workers of high levels of airborne metals in minutes rather than weeks
11. EPA Proposes New Cuts on Levels of Soot in Air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE ... Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, who will ... Administration at St. Thomas University in Miami, Florida, was selected from a pool ...
(Date:9/22/2017)... HOUSTON, Texas (PRWEB) , ... September 22, 2017 ... ... leading network of independent freestanding emergency rooms is celebrating the one year anniversary ... anniversary of our facility opening,” said Dr. Otinwa, Facility Medical Director of First ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... products at customers’ doorstep. According to Smart Mart, customers can now order vegetable, ... offer wearable, and customers can find clothing at discounted prices. Apart from this, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality ... run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves staring ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... in their communities, nine governmental public health departments have been awarded five-year accreditation ... decisions mean that the benefits of being served by a PHAB-accredited health ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: